These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 5826758)
41. [Effectiveness of sulfamethoxypyridazine in the treatment of urinary tract infections]. QUIRNO N; GONDRA MD; RECHNIEWSKI C; ACHAVAL M Dia Med; 1958 Dec; 30(88):3082 passim. PubMed ID: 13609482 [No Abstract] [Full Text] [Related]
42. [Study on therapy of urinary tract infections]. PAUER FJ Wien Med Wochenschr; 1959 Jun; 109(25):528-30. PubMed ID: 13676529 [No Abstract] [Full Text] [Related]
43. [Treatment of urinary tract infections with a new sulfonamide in low dosage]. Bergfors PG Lakartidningen; 1967 Mar; 64():Suppl 1:62-7. PubMed ID: 6042213 [No Abstract] [Full Text] [Related]
44. Azo gantrisin in the treatment of urinary tract infections. TRAFTON HM; LIND HE Int Rec Med Gen Pract Clin; 1957 Dec; 170(12):657-64. PubMed ID: 13491184 [No Abstract] [Full Text] [Related]
45. [Clinical and experimental research on the effectiveness of a depot sulfonamide preparation in urinary tract infections]. BRINKMANN W; LINZENMEIER G Medizinische; 1958 Nov; 32(44):1779-82. PubMed ID: 13612598 [No Abstract] [Full Text] [Related]
46. [Is repeat antibiotic prescription following treatment with sulfonamide or pivmecillinam a valid method for assessment of therapeutic failure in urinary infection?]. Høiby N Ugeskr Laeger; 2003 Nov; 165(45):4316-7. PubMed ID: 14635335 [No Abstract] [Full Text] [Related]
47. The relative importance of blood and urinary concentrations of sulfonamide in the treatment of urinary tract infections; a comparison of sulfisoxazole (gantrisin) and sulfamethoxypyridazine (kynex, midicel) in man and rat. ZIKRIA BA; LASAGNA L; McCANN WP Bull Johns Hopkins Hosp; 1958 Sep; 103(3):117-24. PubMed ID: 13573014 [No Abstract] [Full Text] [Related]
49. Sulphonamide as hemolysis-promoting factor in uremia. Eklund SG; Johansson SV; Lins LE; Strandberg O Scand J Urol Nephrol; 1980; 14(3):275-7. PubMed ID: 7209436 [TBL] [Abstract][Full Text] [Related]
50. [Considerations on the use of cephaloridine in human pathology]. Dioguardi N; Idéo G Minerva Med; 1966 Jun; 57(47):2161-75. PubMed ID: 5939915 [No Abstract] [Full Text] [Related]
51. [Sulfamethoxypyridazine in the treatment of urinary infections]. TRUC E; HENRIET R; POUS JP; TARBOURIECH J; VIDAL A Presse Med (1893); 1959 Mar; 67(13):500-1. PubMed ID: 13633924 [No Abstract] [Full Text] [Related]
52. [Studies on blood-bactericidal power of sulfonamides in urology with euvernil]. WILDE W Munch Med Wochenschr; 1957 Mar; 99(9):302-3. PubMed ID: 13418725 [No Abstract] [Full Text] [Related]
53. Clinical and laboratory observations of sulfamethoxypyridazine (Kynex) in urinary infections. HERROLD RD; KARABATSOS N Postgrad Semin Am Urol Assoc North Cent; 1957; ():42-3. PubMed ID: 13554400 [No Abstract] [Full Text] [Related]
54. Sodium ampicillin given parenterally. Turck M; Smith RH; Wallace JF; Petersdorf RG Arch Intern Med; 1966 Feb; 117(2):242-9. PubMed ID: 5901556 [No Abstract] [Full Text] [Related]
56. [Clinical application of a new sulfanilamide derivative of prolonged action in urinary infections]. BILIOTTI G Minerva Med; 1958 Dec; 49(100):4757-61. PubMed ID: 13622392 [No Abstract] [Full Text] [Related]